Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: A National Population-Based Cohort Study.

Affiliation

Lee HY(#)(1)(2)(3), Ahn J(#)(4), Park J(4), Kyung Kang C(3), Won SH(4)(5), Wook Kim D(6), Park JH(6)(7), Chung KH(8)(9), Joh JS(8), Bang JH(10)(9), Hee Kang C(6), Bum Pyun W(1), Oh MD(1)(2)(3)(9); Korean Society of Hypertension, National Committee for Clinical Management of Emerging Infectious Diseases.
Author information:
(1)Korean Society of Hypertension
(H.-Y.L., W.B.P.).
(2)Department of Internal Medicine, Seoul National University College of Medicine, Korea
(H.-Y.L., M.-d.O.).
(3)Department of Internal Medicine, Seoul National University Hospital, Korea
(H.-Y.L., C.K.K., M.-d.O).
(4)Department of Public Health Sciences
(J.A., J.P., S.-H.W.), Seoul National University, Korea.
(5)Institute of Health and Environment
(S.-H.W.), Seoul National University, Korea.
(6)National Health Insurance Service, Wonju, Korea
(D.W.K., J.-H.P., C.H.K.).
(7)Department of Benefits Strategy, National Health Insurance Service, Wonju, Korea
(J.-H.P.).
(8)National Medical Center, Seoul, Korea
(K.-H.C., J.-S.J.).
(9)National Committee for Clinical Management of Emerging Infectious Diseases, Korea
(K.-H.C., J.H.B., M.-d.O.).
(10)Central Infectious Disease Hospital, Seoul, Korea
(J.H.B.).
(#)Contributed equally

Abstract

Comment in Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):e280-e281.